Bupropion hydrochloride is a generic prescription drug used for depression and seasonal affective disorder. Bupropion comes as oral tablets. Bupropion, also called bupropion hydrochloride, is a ...

From reproductive rights to climate change to Big Tech, The Independent is on the ground when the story is developing. Whether it's investigating the financials of Elon Musk's pro-Trump PAC or ...

Learn more about hydroxyzine, including when dogs may need it, what the right dosage is, and what alternatives you might consider. Always consult with a vet before giving your pet any medication!

“The invitation to speak today is an opportunity to share more about the impact of Biden Cancer Moonshot on cooperative efforts to accelerate promising research in pediatric brain cancer drug ...

Wellness. What was once a whisper on Gwyneth Paltrow’s lips is now a well-recognised concept in our daily lives, and an industry set to hit $9 trillion (£7.25 trillion) by 2028. Whether you’re a ...

Esophageal hypomotility in general and especially ineffective esophageal motility according to the Chicago criteria of primary motility disorders of the esophagus, is one of the most frequently ...

Neuroscientist and international speaker TJ Power shares how the DOSE (Dopamine, Oxytocin, Serotonin, Endorphins) Effect can ...

Dopamine is an inotropic agent that has vasodilatory effects at low doses. It is a common belief that low-dose dopamine may be helpful in the prevention and treatment of acute renal failure and is ...

Dopamine is a neuromodulator that’s known as the “feel-good” hormone, because it’s responsible for making us feel happy and experience pleasure. Released from nerve cells in the brain, it also plays a ...

We often dress according to our mood, with brighter colours and bolder prints signalling an upbeat demeanour and darker, more muted choices when you’re feeling down in the dumps. But what if the roles ...

SAN DIEGO, Jan. 13, 2025 /PRNewswire/ -- Aspen Neuroscience, Inc. has successfully completed dose escalation and the first two cohorts of patients in the ASPIRO study, an ANPD001 Phase 1/2a ...